Legal
Key facts
A securities fraud class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
Key facts
The lawsuit was filed in the United States District Court for the Southern District of California
Key facts
The case is captioned Darren Ngasseu Nkamga v. Capricor Therapeutics, Inc., No. 26-cv-04385 (S.D. Cal.)
Atlas Watchline
A securities fraud class action filed in federal court alleges Capricor Therapeutics misled investors about Deramiocel…